AlphaFold predicted structure
TMEM147 · Q9BVK8

Mean pLDDT
92.5/ 100
Very high
224 residues
Confidence breakdown
- Very high(≥ 90)75%
- Confident(70–90)24%
- Low(50–70)1%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
transmembrane protein 147
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalneurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly
Motor delay
Absent speech
Abnormal facial shape
Severe intellectual disability
Poor speech
hereditary disease
cholelithiasis
gallstones
hepatocellular carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
BOS complex subunit TMEM147
Component of the multi-pass translocon (MPT) complex that mediates insertion of multi-pass membrane proteins into the lipid bilayer of membranes (PubMed:32820719, PubMed:36261522). The MPT complex takes over after the SEC61 complex: following membrane insertion of the first few transmembrane segments of proteins by the SEC61 complex, the MPT complex occludes the lateral gate of the SEC61 complex to promote insertion of subsequent transmembrane regions (PubMed:36261522). Also acts as a negative regulator of CHRM3 function, most likely by interfering with its trafficking to the cell membrane (PubMed:21056967). Negatively regulates CHRM3-mediated calcium mobilization and activation of RPS6KA1/p90RSK activity (PubMed:21056967). Regulates LBR localization to the nucleus inner membrane (PubMed:32694168)
TMEM147 · Q9BVK8

Mean pLDDT
92.5/ 100
Very high
224 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0